Arboleda et al. reported that overexpression of active Akt2, but not Akt1 or Akt3, enhanced invasion through collagen IV matrix via upregulation of β1-integrin in several breast cancer cells and increased metastasis of MDA-MB-435 xenografts [86] (Table 1). The gene discussed is AKT2; the disease is breast carcinoma.